Artemether Completed Phase N/A Trials for Plasmodium Infections / Malaria caused by Plasmodium falciparum / Malaria caused by plasmodium vivax Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT04222088TES Artemether-lumefantrine for Pf and Chloroquine (CQ) for Pv
NCT00203801Combination Antimalarials in Uncomplicated Malaria
NCT01967472Adherence to Antimalarial Drugs in Sierra Leone
NCT02600767Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil
NCT01052584Ethiopia Malaria Therapeutic Efficacy Study
NCT00127998Antimalarial Drug Resistance in Mali
NCT00229775Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines
NCT02213211School-based Programme of Malaria Diagnosis and Treatment in Southern Malawi
NCT01326754Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi
NCT01567423Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria